This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1996-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Forest Hills, NY (US) (1996 - 2006)
- Staten Island, NY (US) (1999 - 2012)
Company Filing History:
Years Active: 1996-2012
Title: The Innovative Contributions of Ron S Israeli
Introduction
Ron S Israeli is a prominent inventor based in Staten Island, NY (US). He has made significant contributions to the field of cancer research, particularly through his work on antibodies related to prostate-specific membrane antigen. With a total of 8 patents to his name, Israeli's innovations are paving the way for advancements in cancer diagnostics and treatment.
Latest Patents
One of his latest patents focuses on antibodies to prostate-specific membrane antigen. This invention provides purified antibodies to the outer membrane domain of prostate-specific membrane (PSM) antigen. It includes compositions of matter comprising PSM antigen antibodies conjugated to a radioisotope or a toxin. Additionally, it outlines a method of imaging prostate cancer by using PSM antigen antibodies. This groundbreaking work has the potential to enhance the accuracy of prostate cancer detection and treatment.
Career Highlights
Ron S Israeli is affiliated with the Sloan Kettering Institute for Cancer Research, where he continues to contribute to innovative cancer research. His work is characterized by a commitment to improving patient outcomes through scientific advancements.
Collaborations
Israeli has collaborated with notable colleagues in the field, including William R Fair and Warren D W Heston. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Ron S Israeli's contributions to cancer research through his innovative patents are noteworthy. His work on antibodies to prostate-specific membrane antigen exemplifies the potential of scientific innovation in improving cancer diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile